Sanara MedTech Management
Management criteria checks 3/4
Sanara MedTech's CEO is Ron Nixon, appointed in May 2024, has a tenure of less than a year. directly owns 11.67% of the company’s shares, worth $33.30M. The average tenure of the management team and the board of directors is 2.5 years and 3.5 years respectively.
Key information
Ron Nixon
Chief executive officer
US$407.5k
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | less than a year |
| CEO ownership | 11.7% |
| Management average tenure | 2.5yrs |
| Board average tenure | 3.5yrs |
Recent management updates
Recent updates
Sanara MedTech (NASDAQ:SMTI) Is Carrying A Fair Bit Of Debt
Dec 19
US$44.00: That's What Analysts Think Sanara MedTech Inc. (NASDAQ:SMTI) Is Worth After Its Latest Results
Nov 15Sanara MedTech Inc. (NASDAQ:SMTI) Looks Just Right With A 28% Price Jump
Sep 05Here's Why Sanara MedTech (NASDAQ:SMTI) Can Afford Some Debt
Aug 14Sanara MedTech Inc.'s (NASDAQ:SMTI) Shares Not Telling The Full Story
May 23Is Sanara MedTech (NASDAQ:SMTI) Using Too Much Debt?
Nov 15Investors Still Waiting For A Pull Back In Sanara MedTech Inc. (NASDAQ:SMTI)
May 22Sanara MedTech Inc. (NASDAQ:SMTI) Analysts Are Pretty Bullish On The Stock After Recent Results
Mar 22Sanara MedTech: Differentiated Offering With Niche Wound Care Exposure
Sep 06Sanara MedTech reports Q2 results
Aug 15Here's Why We're Not At All Concerned With Sanara MedTech's (NASDAQ:SMTI) Cash Burn Situation
Dec 31Sanara MedTech: Technology For Faster Healing Wounds
Dec 08Sanara Medtech inks exclusive partnership with Pixalere Healthcare
Jun 04Companies Like Sanara MedTech (NASDAQ:SMTI) Can Afford To Invest In Growth
May 18Neil Cataldi From Blueprint Discusses Sanara MedTech
May 03The Sanara MedTech (NASDAQ:SMTI) Share Price Has Soared 510%, Delighting Many Shareholders
Feb 19
Is Sanara MedTech Inc. (NASDAQ:SMTI) Popular Amongst Insiders?
Dec 28CEO
Ron Nixon (68 yo)
less than a year
Tenure
US$407,540
Compensation
Mr. Ronald T. Nixon, also known as Ron, has been a Director at Sanara MedTech Inc. (formerly WNDM Medical Inc.) since March 15, 2019 and serves as its Executive Chairman since May 2019 & serves as its Chie...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Executive Chairman & CEO | less than a year | US$407.54k | 11.67% $ 33.3m | |
| CFO & Corporate Secretary | 6.8yrs | US$506.11k | 0.30% $ 848.6k | |
| Chief Operating Officer | less than a year | no data | 0.035% $ 101.2k | |
| Chief Compliance Officer | 5yrs | no data | no data | |
| Vice President of Marketing | no data | no data | no data | |
| Chief Corporate Development & Strategy Officer | less than a year | no data | no data | |
| President of Telehealth Services | 4.3yrs | US$375.69k | no data | |
| President of Research & Development | 3.5yrs | no data | no data | |
| President of Commercial | 1.4yrs | no data | no data | |
| Vice President of Corporate Operations | no data | no data | no data | |
| Executive Officer | no data | no data | no data |
2.5yrs
Average Tenure
56.5yo
Average Age
Experienced Management: SMTI's management team is considered experienced (2.5 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Executive Chairman & CEO | 5.8yrs | US$407.54k | 11.67% $ 33.3m | |
| Independent Director | 3yrs | US$102.53k | 0.16% $ 459.2k | |
| Independent Director | 3yrs | US$97.85k | 0.15% $ 427.6k | |
| Director | less than a year | no data | 0.023% $ 64.5k | |
| Independent Director | 4.3yrs | US$102.53k | 0.22% $ 635.0k | |
| Director | 5.4yrs | US$261.58k | 0.23% $ 649.4k | |
| Independent Director | 1.6yrs | US$93.20k | 0.070% $ 199.4k | |
| Independent Director | 4.1yrs | US$97.85k | 0.20% $ 571.9k |
3.5yrs
Average Tenure
65yo
Average Age
Experienced Board: SMTI's board of directors are considered experienced (3.5 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/21 12:24 |
| End of Day Share Price | 2025/01/17 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Sanara MedTech Inc. is covered by 2 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Ross Osborn | Cantor Fitzgerald & Co. |
| Yi Chen | H.C. Wainwright & Co. |